China Universal Asset Management Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.1K | Sell |
508
-7,514
| -94% | -$623K | ﹤0.01% | 426 |
|
|
2025
Q1 | $651K | Hold |
8,022
| – | – | 0.06% | 219 |
|
|
2024
Q4 | $722K | Sell |
8,022
-15,101
| -65% | -$1.36M | 0.07% | 205 |
|
|
2024
Q3 | $2.28M | Sell |
23,123
-7,833
| -25% | -$774K | 0.25% | 85 |
|
|
2024
Q2 | $2.87M | Sell |
30,956
-3,924
| -11% | -$364K | 0.4% | 56 |
|
|
2024
Q1 | $3.31M | Buy |
34,880
+25,976
| +292% | +$2.46M | 0.42% | 51 |
|
|
2023
Q4 | $795K | Hold |
8,904
| – | – | 0.15% | 125 |
|
|
2023
Q3 | $650K | Hold |
8,904
| – | – | 0.19% | 98 |
|
|
2023
Q2 | $741K | Buy |
8,904
+8,750
| +5,682% | +$728K | 0.23% | 95 |
|
|
2023
Q1 | $11.7K | Sell |
154
-16,783
| -99% | -$1.28M | ﹤0.01% | 272 |
|
|
2022
Q4 | $1.41M | Buy |
16,937
+14,576
| +617% | +$1.21M | 0.57% | 58 |
|
|
2022
Q3 | $187K | Buy |
+2,361
| New | +$187K | 0.08% | 93 |
|